CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 50 filers reported holding CORVUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 5.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $121,000 | -28.0% | 33,968 | -19.1% | 0.00% | -50.0% |
| Q3 2020 | $168,000 | -21.5% | 41,968 | -46.6% | 0.00% | 0.0% |
| Q2 2020 | $214,000 | +28.9% | 78,634 | +0.1% | 0.00% | 0.0% |
| Q1 2020 | $166,000 | -59.8% | 78,576 | +3.4% | 0.00% | -50.0% |
| Q4 2019 | $413,000 | +220.2% | 75,996 | +76.7% | 0.00% | +100.0% |
| Q3 2019 | $129,000 | -42.2% | 43,017 | -28.0% | 0.00% | -33.3% |
| Q2 2019 | $223,000 | +8.3% | 59,718 | +6.3% | 0.00% | -25.0% |
| Q4 2018 | $206,000 | -45.2% | 56,174 | +28.3% | 0.00% | -20.0% |
| Q3 2018 | $376,000 | +159.3% | 43,774 | +212.1% | 0.01% | +66.7% |
| Q4 2017 | $145,000 | – | 14,026 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 3,101,709 | $7,475,000 | 1.50% |
| ADAMS STREET PARTNERS LLC | 3,275,616 | $7,894,000 | 1.20% |
| Telemetry Investments, L.L.C. | 192,909 | $465,000 | 0.60% |
| CHI Advisors LLC | 400,000 | $964,000 | 0.32% |
| Orbimed Advisors | 6,943,654 | $16,734,000 | 0.22% |
| Ikarian Capital, LLC | 482,610 | $1,163,000 | 0.17% |
| Anson Funds Management LP | 528,358 | $1,273,000 | 0.12% |
| BVF INC/IL | 1,370,947 | $3,304,000 | 0.12% |
| VR Adviser, LLC | 250,000 | $603,000 | 0.08% |
| PURA VIDA INVESTMENTS, LLC | 492,384 | $1,187,000 | 0.04% |